Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for Squamous Cell Carcinoma in Renal Transplant Patients
NCT01764607Phase 2Terminated
- Sponsor
- University of Florida
- Start
- Apr 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in squamous cell carcinoma of the skin (SCC), sponsored by University of Florida. Started Apr 2013; status: terminated.
02
Drugs
sirolimus
03
Conditions
squamous cell carcinoma of the skin (SCC)
Beyond the preview
Go deeper on NCT01764607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01764607.